HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$8.70
Day range
$8.78 - $9.30
Year range
$4.44 - $11.80
Market cap
207.37M USD
Avg Volume
126.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.45M | 9.94% |
Net income | -6.25M | 5.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.53M | -3.10% |
Total assets | 18.61M | -3.01% |
Total liabilities | 8.89M | 27.35% |
Total equity | 9.71M | — |
Shares outstanding | 23.39M | — |
Price to book | 17.40 | — |
Return on assets | -89.78% | — |
Return on capital | -155.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.25M | 5.65% |
Cash from operations | -2.46M | 35.97% |
Cash from investing | — | — |
Cash from financing | 3.83M | 317.56% |
Net change in cash | 1.36M | 146.51% |
Free cash flow | -205.62K | 77.51% |
About
Founded
2020
Headquarters
Website
Employees
13
